Cargando…

Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition

Cannabinoid hyperemesis syndrome (CHS) is characterized by episodic bursts of nausea, vomiting and abdominal pain, affecting chronic cannabis users. The clinical picture mimics an acute abdomen, usually leading to multiple assessments in the emergency department. Several complementary diagnostic exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogueira, João Machado, Fonseca, Inês, Duarte, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630388/
https://www.ncbi.nlm.nih.gov/pubmed/34901450
http://dx.doi.org/10.1159/000512088
_version_ 1784607363952541696
author Nogueira, João Machado
Fonseca, Inês
Duarte, Marco
author_facet Nogueira, João Machado
Fonseca, Inês
Duarte, Marco
author_sort Nogueira, João Machado
collection PubMed
description Cannabinoid hyperemesis syndrome (CHS) is characterized by episodic bursts of nausea, vomiting and abdominal pain, affecting chronic cannabis users. The clinical picture mimics an acute abdomen, usually leading to multiple assessments in the emergency department. Several complementary diagnostic examinations are performed with non-specific results, making differential diagnosis puzzling. We present a case of a 42-year-old man, who has been admitted multiple times to the emergency department in the last 3 months for abdominal pain, nausea and vomiting, without triggering factors and improving only with hot water baths. He was evaluated by different specialties, the various complementary diagnostic tests performed showed no significant results, and no definitive diagnosis was obtained. Treatment resulted only in a partial and transient resolution of symptoms. A more detailed medical history revealed cannabis use for more than 5 years, with a recent increase in the amount consumed. After psychoeducation, explaining the risks associated with consumption and its relationship with the clinical symptoms, which resulted in complete suspension of cannabis, there have been no new symptomatic episodes since then. We present an illustrative case of a poorly reported clinical entity despite having a probable significant prevalence, raising awareness in order that clinicians identify and properly manage these cases.
format Online
Article
Text
id pubmed-8630388
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-86303882021-12-09 Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition Nogueira, João Machado Fonseca, Inês Duarte, Marco GE Port J Gastroenterol Clinical Case Study Cannabinoid hyperemesis syndrome (CHS) is characterized by episodic bursts of nausea, vomiting and abdominal pain, affecting chronic cannabis users. The clinical picture mimics an acute abdomen, usually leading to multiple assessments in the emergency department. Several complementary diagnostic examinations are performed with non-specific results, making differential diagnosis puzzling. We present a case of a 42-year-old man, who has been admitted multiple times to the emergency department in the last 3 months for abdominal pain, nausea and vomiting, without triggering factors and improving only with hot water baths. He was evaluated by different specialties, the various complementary diagnostic tests performed showed no significant results, and no definitive diagnosis was obtained. Treatment resulted only in a partial and transient resolution of symptoms. A more detailed medical history revealed cannabis use for more than 5 years, with a recent increase in the amount consumed. After psychoeducation, explaining the risks associated with consumption and its relationship with the clinical symptoms, which resulted in complete suspension of cannabis, there have been no new symptomatic episodes since then. We present an illustrative case of a poorly reported clinical entity despite having a probable significant prevalence, raising awareness in order that clinicians identify and properly manage these cases. S. Karger AG 2020-12-30 /pmc/articles/PMC8630388/ /pubmed/34901450 http://dx.doi.org/10.1159/000512088 Text en Copyright © 2020 by Sociedade Portuguesa de Gastrenterologia Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Clinical Case Study
Nogueira, João Machado
Fonseca, Inês
Duarte, Marco
Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition
title Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition
title_full Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition
title_fullStr Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition
title_full_unstemmed Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition
title_short Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition
title_sort cannabinoid hyperemesis syndrome: a case report of an underdiagnosed condition
topic Clinical Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630388/
https://www.ncbi.nlm.nih.gov/pubmed/34901450
http://dx.doi.org/10.1159/000512088
work_keys_str_mv AT nogueirajoaomachado cannabinoidhyperemesissyndromeacasereportofanunderdiagnosedcondition
AT fonsecaines cannabinoidhyperemesissyndromeacasereportofanunderdiagnosedcondition
AT duartemarco cannabinoidhyperemesissyndromeacasereportofanunderdiagnosedcondition